methyl 4-(4-methoxyphenyl)-2,4-dioxobutanoate, 98.0%, 1g

methyl 4-((3-methyl-1,2,4-oxadiazol-5-yl)methoxy)benzoate, 95.0%, 500mg

{1-[(tert-butoxy)carbonyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}boronic acid, 95.0%, 1g

8-chloro-1-methyl-3,4-dihydro-2H-pyrimido[1,2-c]pyrimidin-6-one, 97%, 500mg

Spray bottles set ROTILABO®, 1 Set

2-PHENYL-2H-1,2,3-TRIAZOL-4-AMINE, 95.0%, 250mg

1-(Adamantane-1-carbonyl)pyrrolidine-2-carboxylic acid, 95+%, 25g

(2E)-1-(3-chlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2-Chloro-5-(2-methoxybenzoyl)pyridine, 97.0%, 500mg

Palladium(II) chloride (metals basis) 99.95% 2 g

(6-(Methylsulfonyl)pyridin-3-yl)boronic acid, 95.0%, 1g

8-(Chloromethyl)-6-fluorobenzo-1,3-dioxan, 95.0%, 10g